| Issuer | % of Class | Filed |
|---|---|---|
|
180 Life Sciences Corp.
13D/A
Amendment 4
ETHZ · 68236V302
|
1.5% |
8/6/2025
Event 7/24/2025
|
|
180 Life Sciences Corp.
13D/A
Amendment 3
ETHZ · 68236V302
|
31.3% |
7/2/2025
Event 6/17/2025
|
|
180 Life Sciences Corp.
13D/A
Amendment 2
ETHZ · 68236V302
|
31.7% |
6/20/2025
Event 6/17/2025
|
|
180 Life Sciences Corp.
13D/A
Amendment 1
ETHZ · 68236V302
|
30.2% |
4/30/2025
Event 4/28/2025
|
|
180 Life Sciences Corp.
13D
ETHZ · 68236V302
|
10.5% |
2/25/2025
Event 2/20/2025
|
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.